RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Volpara Health Technologies - Stock

Volpara Health Technologies P/S 2024

Volpara Health Technologies P/S

8.33

Ticker

VHT.AX

ISIN

NZVHTE0001S6

WKN

A2DVK1

As of Jul 4, 2024, Volpara Health Technologies's P/S ratio stood at 8.33, a 43.87% change from the 5.79 P/S ratio recorded in the previous year.

The Volpara Health Technologies P/S history

Volpara Health Technologies Aktienanalyse

What does Volpara Health Technologies do?

Volpara Health Technologies Ltd is a medical technology company that specializes in offering products and services for breast cancer diagnosis and treatment. The company was founded in 2009 in New Zealand and has its headquarters in Wellington, as well as branches in the US, UK, and Australia. The business model of Volpara revolves around providing a cloud-based software platform called VolparaEnterprise, specifically developed for breast cancer diagnosis and treatment. This platform offers radiologists and radiological screening centers a complete range of tools to assess risks, make diagnoses, and plan treatments. It integrates automatic image analysis, artificial intelligence, and machine learning to enable more accurate and faster screenings. Volpara also assists in the interpretation of mammography images, particularly in assessing breast density, which is an important risk factor for the development of breast cancer. The company has developed a range of products, including VolparaDensity, VolparaLive! (formerly MRS), VolparaScore, and VolparaHealthchecks. Volpara has several divisions focusing on different aspects of breast cancer diagnosis and treatment: 1. VolparaClinical: This division is responsible for developing products for breast cancer diagnosis and assessment. These products include automated image analysis software and services for radiologists. 2. VolparaResearch: This division conducts clinical studies and research activities to expand knowledge and understanding of breast cancer. 3. VolparaEnterprise: This division offers a cloud-based software platform for radiological screening centers. The platform enables monitoring of image quality, risk assessment, disaster management, and continuing education for image screeners. 4. Volpara Solutions: This division is responsible for developing solutions for clinical decision support and patient management. The products offered by Volpara include VolparaDensity, an automated software for assessing women's breast density, VolparaLive!, an image analysis software for real-time monitoring of mammography image quality, VolparaScore, an automated software for assessing women's breast cancer risk, and VolparaHealthchecks, a set of tools for monitoring and treating breast cancer patients and assessing the risk for women with higher breast density. In conclusion, Volpara Health Technologies Ltd is a leading company in breast cancer diagnosis and treatment. The company aims to improve the efficiency and accuracy of mammography screenings and precise diagnosis of breast cancer. With a wide range of products and services, Volpara Health Technologies Ltd is on the right path to saving lives and winning the battle against breast cancer. Volpara Health Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Volpara Health Technologies's P/S Ratio

Volpara Health Technologies's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Volpara Health Technologies's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Volpara Health Technologies's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Volpara Health Technologies’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Volpara Health Technologies stock

What is the price-to-earnings ratio of Volpara Health Technologies?

The price-earnings ratio of Volpara Health Technologies is currently 8.33.

How has the price-earnings ratio of Volpara Health Technologies changed compared to last year?

The price-to-earnings ratio of Volpara Health Technologies has increased by 43.87% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Volpara Health Technologies high compared to other companies?

Yes, the price-to-earnings ratio of Volpara Health Technologies is high compared to other companies.

How does an increase in the price-earnings ratio of Volpara Health Technologies affect the company?

An increase in the price-earnings ratio of Volpara Health Technologies would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Volpara Health Technologies affect the company?

A decrease in the price-earnings ratio of Volpara Health Technologies would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Volpara Health Technologies?

Some factors that influence the price-earnings ratio of Volpara Health Technologies are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Volpara Health Technologies pay?

Over the past 12 months, Volpara Health Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Volpara Health Technologies is expected to pay a dividend of 0 NZD.

What is the dividend yield of Volpara Health Technologies?

The current dividend yield of Volpara Health Technologies is .

When does Volpara Health Technologies pay dividends?

Volpara Health Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Volpara Health Technologies?

Volpara Health Technologies paid dividends every year for the past 0 years.

What is the dividend of Volpara Health Technologies?

For the upcoming 12 months, dividends amounting to 0 NZD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Volpara Health Technologies located?

Volpara Health Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Volpara Health Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Volpara Health Technologies from 7/4/2024 amounting to 0 NZD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Volpara Health Technologies pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Volpara Health Technologies in the year 2023?

In the year 2023, Volpara Health Technologies distributed 0 NZD as dividends.

In which currency does Volpara Health Technologies pay out the dividend?

The dividends of Volpara Health Technologies are distributed in NZD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Volpara Health Technologies

Our stock analysis for Volpara Health Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Volpara Health Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.